Jove
Visualize
Contact Us

Related Experiment Videos

Perspectives on dynamic optimisation and control theory in treating hyperlipidaemia

John A Vernon

    Pharmacoeconomics
    |July 6, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Future of drug development: the economics of pharmacogenomics.

    Expert review of clinical pharmacology·2014
    Same author

    Considering the economic principles of pharmaceutical R&D.

    Expert opinion on drug discovery·2013
    Same author

    Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislation.

    Paediatric drugs·2012
    Same author

    The case for less, not more, US FDA regulation.

    PharmacoEconomics·2011
    Same author

    Correctly measuring drug development risk: a public policy imperative.

    Expert review of pharmacoeconomics & outcomes research·2011
    Same author

    Comparative effectiveness regulations and pharmaceutical innovation.

    PharmacoEconomics·2010
    Same journal

    Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

    PharmacoEconomics·2026
    Same journal

    Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

    PharmacoEconomics·2026
    Same journal

    Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

    PharmacoEconomics·2026
    Same journal

    A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

    PharmacoEconomics·2026
    Same journal

    Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

    PharmacoEconomics·2026
    Same journal

    Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

    PharmacoEconomics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies